Protalix BioTherapeutics’ (PLX) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price objective on the stock. HC Wainwright also issued estimates for Protalix BioTherapeutics’ Q4 2023 earnings at ($0.03) EPS, FY2023 earnings at $0.16 EPS and […]
More Stories
Mousetrap: K-drama: Release Date, Trailer, Cast Members, and More
If you love intense drama with lots of thriller and psychological tension, then I have some good news for you....
Dylan Jagger Lee and Paula Bruss are Married! Know the Wedding Venue and Other Details
Have you also heard the news about Pamela’s son getting married? Yes, the news is correct! Dylan Jagger Lee, the...
The Map of Longing: Release Date, Cast Members, Trailer, and Synopsis
Are you ready for an emotional and loving journey between two sisters? If you are a fan of a chaotic...
Netflix has announced the Release Date for Steps, a Cinderella Spin-Off
Mark your calendar! Netflix has brought an all-new anime film, Steps, for a 2026 release. The film flips the classic...
Avatar: The Last Airbender Season 3: Release Date, Trailer, and Cast Members
Everyone’s favourite animated series, Avatar: The Last Airbender, is coming back with more action-packed visuals to captivate its audience once...
Cyberpunk: Edgerunners Season 2: Release Date, Cast, Trailer, and More
Night City is coming again with its renewal after four years of waiting. Since its first release in 2022, the...